The Drug Vehicle and Solvent N-Methylpyrrolidone Is an Immunomodulator and Antimyeloma Compound

Jake Shortt; Andy K Hsu; Benjamin P Martin; Karen Doggett; Geoffrey M Matthews; Maria A Doyle; Jason Ellul; Tina E Jockel; Daniel M Andrews; Simon J Hogg; Andrea Reitsma; David Faulkner; P Leif Bergsagel; Marta Chesi; Joan K Heath; William A Denny; Philip E Thompson; Paul J Neeson; David S Ritchie; Grant A McArthur; Ricky W Johnstone

Journal article

The Drug Vehicle and Solvent N-Methylpyrrolidone Is an Immunomodulator and Antimyeloma Compound

Jake Shortt, Andy K Hsu, Benjamin P Martin, Karen Doggett, Geoffrey M Matthews, Maria A Doyle, Jason Ellul, Tina E Jockel, Daniel M Andrews, Simon J Hogg, Andrea Reitsma, David Faulkner, P Leif Bergsagel, Marta Chesi, Joan K Heath, William A Denny, Philip E Thompson, Paul J Neeson, David S Ritchie, Grant A McArthur Show all

Cell Reports | CELL PRESS | Published : 2014

DOI: 10.1016/j.celrep.2014.04.008

University of Melbourne Researchers

Grant McArthur Author Melbourne Medical School

Jake Shortt Author The Sir Peter MacCallum Department of Oncology

Jason Ellul Author The Sir Peter MacCallum Department of Oncology

Karen Doggett Author Surgery - Royal Melbourne Hospital

Paul Neeson Author The Sir Peter MacCallum Department of Oncology

Grants

Funding Acknowledgements

The authors thank Prof. James Bradner and Prof. Constantine Mitsiades for advice and critical evaluation of experimental data. Dr. Chris Ott and Dr. Gang Lu provided assistance with IKZF assays. J.S. is supported by the Leukaemia Foundation of Australia and the Co-operative Research Centre for Biomedical Imaging Development. T.E.J. is supported by Deutsche Krebshilfe. R.W.J. is a Principal Research Fellow of the National Health and Medical Research Council (NHMRC) of Australia and supported by NHMRC Program and Project Grants, Cancer Council Victoria, the Leukaemia Foundation of Australia, and the Victorian Cancer Agency.